Loading clinical trials...
Loading clinical trials...
Evaluation of Right Ventricular Function and Metabolism Following Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension- Images of Rio
Conditions
Interventions
Cardiac PET imaging using F-18-FDG, N-13 ammonia( NH3)
Locations
1
Canada
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Start Date
May 1, 2014
Primary Completion Date
June 1, 2016
Completion Date
June 1, 2016
Last Updated
August 29, 2018
NCT06526468
NCT04206852
NCT03388476
NCT07172334
NCT06384534
NCT03102294
Lead Sponsor
Ottawa Heart Institute Research Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions